![]() |
Volumn 6, Issue 4, 2001, Pages 261-265
|
Treatment of relapsing Ph+ acute lymphoblastic leukemia with donor leukocyte infusion followed by quantitative monitoring of residual disease
a
a
|
Author keywords
Donor leukocyte infusion; Leukemic relapse; Molecular monitoring; Real time RT PCR
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
MESSENGER RNA;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOXANTRONE;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
VINDESINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CASE REPORT;
CELL CLONE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DISEASE COURSE;
DONOR;
GRAFT VERSUS HOST REACTION;
HUMAN;
INTERMETHOD COMPARISON;
LEUKEMIA REMISSION;
LEUKOCYTE TRANSFUSION;
MALE;
MEDICAL ASSESSMENT;
MINIMAL RESIDUAL DISEASE;
PATIENT MONITORING;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
RECURRENT DISEASE;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
WHOLE BODY RADIATION;
|
EID: 0035721485
PISSN: 10245332
EISSN: None
Source Type: Journal
DOI: 10.1080/10245332.2001.11746579 Document Type: Article |
Times cited : (4)
|
References (11)
|